Skip to content

Comparison of efficacy of Halita mouthrine with chlorhexidine mouthrine in reducing oral malodor in patients with oral malador

Clinical trial of comparison of efficacy of Halita mouthrine with chlorhexidine mouthrine in reducing oral malodor in patients with halitosis in 7-day consumption

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014121520314N1
Enrollment
50
Registered
2015-02-23
Start date
2014-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral halitosis. Halitosis

Interventions

Intervention 1: 0.05% chlorhexidine mouth rinse in 140 ml volume for 7-day use (14 doses) 10 ml for one dose. Intervention 2: Halita(containing 0.05% chlorhexidine, 0.05% cetylpyridinium chloride
Treatment - Drugs
0.05% chlorhexidine mouth rinse in 140 ml volume for 7-day use (14 doses) 10 ml for one dose.
Halita(containing 0.05% chlorhexidine, 0.05% cetylpyridinium chloride, and zinc) mouth rinse in 140 ml volume for 7-day use (14 doses) 10 ml for one dose.

Sponsors

Vice chancellor for research, faculty of dentistry, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
17 Years to 26 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Organoleptic score (OLS) of over 2. Exclusion criteria: Alcohol and tobacco use; Systemic diseases; Medications that cause dry mouth; Consumption of antibiotics in the previous two weeks; Pocket depth greater than 6 mm; Eating spicy foods, onion, and garlic 48 hours prior to the examination; Use of orthodontic appliances (fixed or removable) and removable dental prosthesis; Allergy or any undesirable reactions to either of test mouthrinses. It should be noted that, during the study period, the participants did not receive dental procedures such as scaling, restoration, etc. and thus their oral health conditions were unchanged.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Oral halitosis. Timepoint: before intervention and after 7 days of intervention. Method of measurement: Organoleptic measurement.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSiamand Ebrahimi

Tabriz University of Medical Sciences

Z.jamali55@gmail.com+98 41 3335 7314

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026